Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.diabres.2017.08.018PMID 28934669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic approaches for diabetic cardiomyopathy

  2017cited by this paper
• ERK1/2 signaling is required for the initiation but not progression of TGF&bgr;‐induced lens epithelial to mesenchymal transition (EMT)

  2017cited by this paper
• The role of transforming growth factor (TGF)-β in the infarcted myocardium.

  2017cited by this paper
• Osthole inhibits the expressions of collagen I and III through Smad signaling pathway after treatment with TGF-β1 in mouse cardiac fibroblasts.

  2017cited by this paper
• MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1

  2017cited by this paper
• Regulation of TGF-β Family Signaling by Inhibitory Smads.

  2017cited by this paper
• Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy

  2017cited by this paper
• Dietary oxidized tyrosine (O-Tyr) stimulates TGF-β1-induced extracellular matrix production via the JNK/p38 signaling pathway in rat kidneys

  2017cited by this paper
• The role of SIRT1 in diabetic cardiomyopathy.

  2017cited by this paper
• The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels.

  2017cited by this paper
• Fibrosis quantification in Hypertensive Heart Disease with LVH and Non-LVH: Findings from T1 mapping and Contrast-free Cardiac Diffusion-weighted imaging

  2017cited by this paper
• Revisiting the regulatory roles of the TGF-β family of cytokines.

  2016cited by this paper
• Expression profiles of long noncoding RNAs in cardiac stem cells under hyperglycemic conditions.

  2016cited by this paper
• Cardiac Fibrosis: The Fibroblast Awakens.

  2016cited by this paper
• Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research

  2016cited by this paper
• Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD

  2016cited by this paper
• Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway

  2016cited by this paper
• PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling.

  2016cited by this paper
• Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts

  2016cited by this paper
• Hypoxia drives the transition of human dermal fibroblasts to a myofibroblast-like phenotype via the TGF-β1/Smad3 pathway

  2016cited by this paper
• Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure

  2016cited by this paper
• Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes

  2016cited by this paper
• Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

  2016cited by this paper
• Proteins involved on TGF-β pathway are up-regulated during the acute phase of experimental Chagas disease.

  2016cited by this paper
• TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.

  2016cited by this paper
• LCZ696, an angiotensin receptor–neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin‐induced diabetic mice

  2016cited by this paper
• Native T1 mapping in patients with idiopathic dilated cardiomyopathy for the assessment of diffuse myocardial fibrosis: validation against histologic endomyocardial biopsy

  2015cited by this paper
• Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat

  2015cited by this paper
• MRI reveals hemodynamic changes with acute maternal hyperoxygenation in human fetuses with and without congenital heart disease

  2015cited by this paper
• Caveolin‐1 as a Potential Regulator of Transforming Growth Factor‐β and Angiotensin II Type 1 Receptor Signaling in Primary Human Aortic Smooth Muscle Cells

  2015cited by this paper
• Study on Diastolic Dysfunction in Newly Diagnosed Type 2 Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin (HbA1C).

  2015cited by this paper
• How to estimate left ventricular hypertrophy in hypertensive patients.

  2014cited by this paper
• Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission.

  2014cited by this paper
• Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Functional and structural impact of pirfenidone on the alterations of cardiac disease and diabetes mellitus.

  2014cited by this paper
• Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.

  2014cited by this paper
• An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.

  2013cited by this paper
• Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation.

  2013cited by this paper
• Diabetic cardiomyopathy and diastolic heart failure -- difficulties with relaxation.

  2012cited by this paper
• Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid

  2012cited by this paper
• Diabetes mellitus, a microRNA-related disease?

  2011cited by this paper
• Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association

  2011cited by this paper
• Diabetes Mellitus Worsens Diastolic Left Ventricular Dysfunction in Aortic Stenosis Through Altered Myocardial Structure and Cardiomyocyte Stiffness

  2011cited by this paper
• Epigenetics and diabetic cardiomyopathy.

  2011cited by this paper
• β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions.

  2011cited by this paper
• Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.

  2010cited by this paper
• Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.

  2009cited by this paper
• Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

  2008influential reference
• Mechanisms of Cardiac Fibrosis in Hypertension

  2007cited by this paper
• High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2

  2007cited by this paper
• Leptin induces TGF-beta synthesis through functional leptin receptor expressed by human peritoneal mesothelial cell.

  2006cited by this paper
• Diabetes in heart failure: prevalence and impact on outcome in the population.

  2006cited by this paper
• Diastolic Dysfunction in Hypertensive Hearts: Roles of Perivascular Inflammation and Reactive Myocardial Fibrosis

  2005cited by this paper
• SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes.

  2005cited by this paper
• Hypothetical economic analysis of screening for left ventricular hypertrophy in high-risk normotensive populations.

  2004cited by this paper
• Impact of Basic Research on Tomorrow's MedicineThe Role of Transforming Growth Factor β in Lung Development and Disease

  2004cited by this paper
• Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

  2004cited by this paper
• Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

  2003cited by this paper
• Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus

  2003cited by this paper
• Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression.

  2001cited by this paper
• Leptin stimulates type I collagen production in db/db mesangial cells: Glucose uptake and TGF-β type II receptor expression

  2001cited by this paper
• Diabetes and cardiovascular disease.

  1999cited by this paper
• Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion.

  1997cited by this paper
• Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus.

  1996cited by this paper
• Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus

  1996cited by this paper
• Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo.

  1991cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• New type of cardiomyopathy associated with diabetic glomerulosclerosis.

  1972cited by this paper
• International Journal of Molecular Sciences the Role of P38 Mapk in the Development of Diabetic Cardiomyopathy

  year unknowncited by this paper
• International Journal of Molecular Sciences the Role of Erk1/2 in the Development of Diabetic Cardiomyopathy

  year unknowncited by this paper

• PANoptosis in diabetes: immunometabolic insights and treatments

  2026cites this paper
• Micro Zhēngjiǎ as a reversible microstructural lesion network in diabetic myocardial fibrosis: mechanistic insights and therapeutic implications of Huoxue-Tongluo therapy.

  2026cites this paper
• Exploring the Role and Mechanism of DSF in HFpEF Based on IL-1β/IL-1βR/TAK1/RIPK1 Axis-Mediated PANoptosis.

  2026cites this paper
• Indole-3-carbinol alleviates cisplatin-induced ovarian damage by inhibiting ovarian fibrosis through the TGF-β1/Smad pathway

  2026cites this paper
• Beneficial Effects of Different Types of Exercise on Diabetic Cardiomyopathy

  2025cites this paper
• 1,25-dihydroxyvitamin D3 attenuates type 1 diabetes-related myocardial apoptosis and fibrosis by influencing the interaction of FoxO1 and p-Smad3.

  2025cites this paper
• The role of Nrf2 signaling pathway in diabetic cardiomyopathy: from pathogenesis to traditional Chinese medicine interventions

  2025cites this paper
• The Roles of Flavonoids and Other Plant‐Based Phenolics in Mitigating Diabetes‐Induced Macrovascular Complications

  2025cites this paper
• TGF-β-driven EMT in cancer progression and drug resistance.

  2025cites this paper
• Exercise Empowerment: A Multifaceted Anatomy in Managing Diabetic Myocardial Disorder

  2025cites this paper
• Expression patterns and clinical relevance of H19, miR-181a-3p, and TGF-β in ascending aortic aneurysms: a comparative analysis of human aortic tissue

  2025cites this paper
• TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension

  2025cites this paper
• Endothelial dysfunction as a driver of microvascular injury in diabetic cardiomyopathy

  2025cites this paper
• Reprogramming of lipids and amino acids metabolism is an early event in myocardium of type 1 diabetic rhesus monkeys.

  2025cites this paper
• miR-132 inhibition improves cardiac remodeling and function in a two-hit mouse model of heart failure with a preserved ejection fraction.

  2025cites this paper
• Mechanistic exploration of hexokinase 2 and metabolism in diabetic cardiomyopathy

  2025influential citation
• TGFBR1 gene silencing attenuates cardiomyopathy in the HFpEF mouse model

  2025cites this paper
• piRNA, the hidden player in cardiac fibrosis: A review.

  2025cites this paper
• Targeting inhibition of the inflammatory response: advances in the treatment of myocardial fibrosis with natural medicine and active ingredients

  2025cites this paper
• Deletion of CHOP in beta cell protects mice from cardiovascular complications in type 2 diabetes: evidence from a pre-clinical mouse model

  2025cites this paper
• Structural Characterization and Protective Effect Against Myocardial Fibrosis of Polysaccharide from Stellariae Radix (Stellaria Dichotoma L. Var. lanceolata Bge.)

  2025cites this paper
• Microencapsulated 3D culture of human umbilical cord-derived mesenchymal stem cells enhances their therapeutic effect on intrauterine adhesion

  2025cites this paper
• Global Research Trends in Oxidative Stress and Myocardial Fibrosis: A Dual-Software Bibliometric Study

  2025cites this paper
• Oral edaravone ameliorates myocardial fibrosis in type 2 diabetic rats by TGF-β1/Smad signaling pathway.

  2025cites this paper
• Novel Drug Targets in Diastolic Heart Disease

  2025cites this paper
• Revolutionizing cardiac fibrosis treatment: the potential of personalized CAR T-cell therapy

  2025cites this paper
• Mechanisms of circular RNAs in diabetic cardiomyopathy: biological characteristics and clinical prospects

  2025cites this paper
• Novel angiotensin receptor target as therapy for the diabetic heart: the AT2R.

  2025cites this paper
• Per- and Polyfluoroalkyl Substances Induce Cardiotoxicity and Alter Protein Profiles of Extracellular Matrix, Metabolism, and Mitochondrial Function in Human Cardiomyocytes

  2025cites this paper
• Exercise and dietary interventions in the management of diabetic cardiomyopathy: mechanisms and implications

  2025cites this paper
• Emerging Mechanistic Insights and Therapeutic Strategies for Pulmonary Arterial Hypertension: A Focus on Right Ventricular Dysfunction and Novel Treatment Pathways

  2025cites this paper
• ALK5 kinase inhibitors in drug discovery: Structural insights and therapeutic applications.

  2025cites this paper
• Methylophiopogonanone A alleviates diabetic cardiomyopathy via inhibiting JNK1 signaling.

  2025cites this paper
• Non-coding RNAs affecting NLRP3 inflammasome pathway in diabetic cardiomyopathy: a comprehensive review of potential therapeutic options

  2025cites this paper
• Study of independent diagnostic efficacy and co-diagnostic strategies of molecular markers for diabetic cardiomyopathy

  2025cites this paper
• AI-based Predictive Signaling Pathway Profiling in Cardiac Fibrosis Suggests a Novel Combinatorial Treatment Strategy

  2025cites this paper
• Bioactive Fraction of Processed Curcumae Rhizoma-Sparganii Rhizoma Anti-liver Fibrosis by Regulate Taurine Metabolism through PI3K/AKT Pathway.

  2025cites this paper
• Cell Death in Acute Organ Injury and Fibrosis

  2024cites this paper
• Protective effects of carvacrol on lipid profiles, oxidative stress, hypertension, and cardiac dysfunction – A comprehensive review

  2024cites this paper
• Synthesis of amide derivatives containing the imidazole moiety and evaluation of their anti‐cardiac fibrosis activity

  2024cites this paper
• NF‐κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation

  2024cites this paper
• Interleukin-1β polarization in M1 macrophage mediates myocardial fibrosis in diabetes.

  2024cites this paper
• Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics

  2024cites this paper
• Construction of a potentially functional long noncoding RNA-microRNA-mRNA network in diabetic cardiomyopathy

  2024cites this paper
• Myocardial Fibrosis in Diabetic Cardiomyopathy: Mechanisms, Implications, and Therapeutic Perspectives.

  2024cites this paper
• Molecular Pathways in Diabetic Cardiomyopathy and the Role of Anti-hyperglycemic Drugs Beyond Their Glucose Lowering Effect

  2024cites this paper
• Polysaccharides from Sacha Inchi shell reduces renal fibrosis in mice by modulating the TGF-β1/Smad pathway and intestinal microbiota.

  2024cites this paper
• The enhancing effects of selenomethionine on harmine in attenuating pathological cardiac hypertrophy via glycolysis metabolism

  2024cites this paper
• Diabetic Cardiomyopathy: Role of Cell Death, Exosomes, Fibrosis and Epicardial Adipose Tissue

  2024cites this paper
• Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy

  2024cites this paper
• FTMT-dependent mitophagy is crucial for ferroptosis resistance in cardiac fibroblast.

  2024cites this paper
• Potential pathogenic roles of ferroptosis and cuproptosis in cadmium-induced or exacerbated cardiovascular complications in individuals with diabetes

  2024cites this paper
• Cardiomyocyte-derived small extracellular vesicle: a new mechanism driving diabetic cardiac fibrosis and cardiomyopathy

  2024influential citation
• Interval training suppresses nod-like receptor protein 3 inflammasome activation to improve cardiac function in myocardial infarction rats by hindering the activation of the transforming growth factor-β1 pathway

  2024cites this paper
• Patchouli Alcohol Protects the Heart against Diabetes-Related Cardiomyopathy through the JAK2/STAT3 Signaling Pathway

  2024cites this paper
• TRPV4 overactivation enhances cellular contractility and drives ocular hypertension in TGFβ2 overexpressing eyes

  2024cites this paper
• Full Title: Single-cell analysis reveals lysyl oxidase (Lox)+ fibroblast subset involved in cardiac fibrosis of diabetic mice.

  2023cites this paper
• Single-cell analysis reveals lysyl oxidase (Lox)+ fibroblast subset involved in cardiac fibrosis of diabetic mice

  2023cites this paper
• A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy

  2023cites this paper
• Silencing FHL2 inhibits bleomycin-induced pulmonary fibrosis through the TGF-β1/Smad signaling pathway.

  2023cites this paper
• Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation

  2023cites this paper
• Transforming growth factor-β and bone morphogenetic protein signaling pathways in pathological cardiac hypertrophy

  2023cites this paper
• Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway

  2023cites this paper
• Protective effects of catalpol on cardio-cerebrovascular diseases: A comprehensive review

  2023cites this paper
• Role of the integrin-linked kinase/TGF-β/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy.

  2023cites this paper
• GDF11 and aging biology - controversies resolved and pending

  2023cites this paper
• Exosome-Based Regimen Rescues Endometrial Fibrosis in Intrauterine Adhesions Via Targeting Clinical Fibrosis Biomarkers

  2023cites this paper
• Beyond the Beat: A Pioneering Investigation into Exercise Modalities for Alleviating Diabetic Cardiomyopathy and Enhancing Cardiac Health.

  2023cites this paper
• Oridonin Attenuates Diabetes‑induced Renal Fibrosis via the Inhibition of TXNIP/NLRP3 and NF‑κB Pathways by Activating PPARγ in Rats

  2023cites this paper
• Liraglutide Suppresses Myocardial Fibrosis Progression by Inhibiting the Smad Signaling Pathway

  2023cites this paper
• N-glycosylation-mediated CD147 accumulation induces cardiac fibrosis in the diabetic heart through ALK5 activation

  2023influential citation
• Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance

  2023cites this paper
• NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways

  2023cites this paper
• GPCRs and fibroblast heterogeneity in fibroblast‐associated diseases

  2023cites this paper
• Circ-AMOTL1 enhances cardiac fibrosis through binding with EIF4A3 and stabilizing MARCKS expression in diabetic cardiomyopathy.

  2023cites this paper
• Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways

  2023cites this paper
• Cardiac Fibroblast Activation Induced by Oxygen–Glucose Deprivation Depends on the HIF-1α/miR-212-5p/KLF4 Pathway

  2023cites this paper
• Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathways.

  2023cites this paper
• Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice

  2023cites this paper
• Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart

  2023cites this paper
• Chinese medicine supplementing Qi and activating blood circulation relieves the progression of diabetic cardiomyopathy.

  2023cites this paper
• Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy

  2023cites this paper
• Gentianella acuta-derived Gen-miR-1 suppresses myocardial fibrosis by targeting HAX1/HMG20A/Smads axis to attenuate inflammation in cardiac fibroblasts.

  2023cites this paper
• The combination of exercise and metformin inhibits TGF-β1/Smad pathway to attenuate myocardial fibrosis in db/db mice by reducing NF-κB-mediated inflammatory response.

  2023cites this paper
• THE ROLE OF GROWTH FACTORS IN THE DEVELOPMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS

  2023cites this paper
• Geniposide alleviates pressure overload in cardiac fibrosis with suppressed TGF-β1 pathway.

  2023cites this paper
• MiR-29c alleviates hyperglycemia-induced inflammation via targeting TGF-β in cardiomyocytes

  2023cites this paper
• The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis

  2022cites this paper
• The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy

  2022cites this paper
• Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF‐β1/Smad3 signalling pathway

  2022cites this paper
• The Effect of Eugenol Treatment on Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats

  2022cites this paper
• Molecular mechanisms of sacubitril/valsartan in cardiac remodeling

  2022cites this paper
• TGF-beta signal transduction: biology, function and therapy for diseases

  2022cites this paper
• Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy

  2022cites this paper
• Potential Biological Mediators of Myocardial and Vascular Complications of Air Pollution-A State-of-the-Art Review.

  2022cites this paper
• Roflumilast-Mediated Phosphodiesterase 4D Inhibition Reverses Diabetes-Associated Cardiac Dysfunction and Remodeling: Effects Beyond Glucose Lowering.

  2022cites this paper
• Activin receptor-like kinase 7 silencing alleviates cardiomyocyte apoptosis, cardiac fibrosis, and dysfunction in diabetic rats

  2022cites this paper
• Involvement of long non-coding RNA ZNF503 antisense RNA 1 in diabetic retinopathy and its possible underlying mechanism

  2022cites this paper
• Effects of Kangdaxin on myocardial fibrosis in heart failure with preserved ejection fraction rats

  2022cites this paper
• Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts

  2022cites this paper